Dechra options exercised

Dechra Pharmaceuticals directors Ian Page and Tony Griffin have exercised 124,375 and 32,849 nil cost share options respectively. The options were granted to them on 27 November 2013 under the Dechra Pharmaceuticals PLC Long Term Incentive Plan. The exercise of the options was subject to the achievement of performance conditions which vested at 96.25% of the total award.

At 8:45am: (LON:DPH) Dechra Pharmaceuticals PLC share price was +4p at 1276p